Official/authorized website • Research and educational information does not replace individualized medical care.
Video library

Dr. Makis on Repurposed Medicines

Watch selected YouTube discussions and featured interviews with Dr. William Makis covering ivermectin, fenbendazole, mebendazole, metabolic health and emerging cancer research.

Featured discussions

Ivermectin & repurposed-drug research

Long-form conversations exploring the scientific rationale, emerging evidence and continuing debate around medicines being studied for potential use in cancer research.

Featured Interview

Repurposed Drugs for Cancers

Dr. Makis joins Dr. John Campbell for a detailed discussion of ivermectin, fenbendazole, mebendazole and the research surrounding repurposed medicines.

Watch on YouTube →
Ivermectin

Ivermectin and Cancer

A focused discussion with Dr. Makis on ivermectin’s proposed mechanisms, laboratory research and the questions that still require clinical investigation.

Watch on YouTube →
Featured Interview

Turbo Cancers and Repurposed Drugs

Dr. Makis discusses cancer concerns, patient advocacy and the developing research conversation around repurposed medicines.

Watch on YouTube →
Benzimidazoles

Fenbendazole, Cancer and the Science

A research-focused conversation covering fenbendazole, related benzimidazoles and the distinction between preclinical findings and established clinical evidence.

Watch on YouTube →
Podcast Appearance

Fasting for Cancer? Dr. William Makis

A Sowing Prosperity podcast conversation on ivermectin, fenbendazole, fasting and metabolic approaches discussed in cancer research.

Watch on YouTube →
Featured Interview

Is This Finally the Cure for Cancer?

A long-form appearance featuring Dr. Makis discussing ivermectin, repurposed-drug research and the limits of current clinical evidence.

Watch on YouTube →
Educational notice: These videos discuss emerging and sometimes preliminary research. Inclusion in this library does not establish safety, effectiveness or approval for treating cancer. Patients should review treatment decisions with a qualified healthcare professional.